Add-on Acquisition • Food

Ajinomoto Acquires V2 Food

On August 7, 2025, Ajinomoto acquired food company V2 Food

Acquisition Context

This is Ajinomoto’s 6th transaction in the Food sector.
This is Ajinomoto’s 1st transaction in Australia.

Explore All 2129 Add-on Acquisition Food Deals - Search the Database Free

M&A Deal Summary
Date	August 7, 2025
Target	V2 Food
Sector	Food
Buyer(s)	Ajinomoto
Deal Type	Add-on Acquisition

Target Company

V2 Food

Sydney, Australia

V2 Food develops and markets sustainable food products using plant-based proteins. The company has built a supply chain in partnership with the meat industry, enabling it to deliver products at accessible price points. It also partners with the Commonwealth Scientific and Industrial Research Organisation, an Australian government research institute, to develop green food technologies. V2 Food was formed in 2019 and is based in Sydney, Australia.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Ajinomoto

Tokyo, Japan

Category	Company
Founded	1909
Sector	Food
Employees	34,860
Revenue	1.53T JPY (2025)

DESCRIPTION

Ajinomoto is a manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. Ajinomoto was incorporated in 1909 and is based in Tokyo, Japan.

Deal Context for Buyer	#
Overall	10 of 10
Sector: Food	6 of 6
Type: Add-on Acquisition	6 of 6
Country: Australia	1 of 1
Year: 2025	2 of 2

PREVIOUS DEAL

DATE	TARGET	DEAL TYPE	VALUE
2025-04-24	Althea San Diego, California, United States Althea is a fully integrated, contract development and manufacturing organization providing clinical and commercial product development services. The company offers cGMP drug product filling in both vials and syringes, and production of microbial-derived recombinant proteins and plasmid DNA. In conjunction with these manufacturing operations, Althea offers comprehensive development services including: upstream and downstream process development, analytical development, complex formulation, product release, and ICH-compliant stability testing. Its formulation technology platform includes Crystalomics, a proprietary technology that offers a formulation solution for large molecule products that must be delivered at high concentrations or as sustained release formulations. Althea is based in San Diego, California.	Sell	-

DATE

TARGET

DEAL TYPE

VALUE

2025-04-24

Althea

San Diego, California, United States

Althea is a fully integrated, contract development and manufacturing organization providing clinical and commercial product development services. The company offers cGMP drug product filling in both vials and syringes, and production of microbial-derived recombinant proteins and plasmid DNA. In conjunction with these manufacturing operations, Althea offers comprehensive development services including: upstream and downstream process development, analytical development, complex formulation, product release, and ICH-compliant stability testing. Its formulation technology platform includes Crystalomics, a proprietary technology that offers a formulation solution for large molecule products that must be delivered at high concentrations or as sustained release formulations. Althea is based in San Diego, California.

Sell

Explore Related M&A Activity

Food M&A - Add-on Acquisition M&A Deals - Australia M&A - 2025 M&A